Publications by authors named "Pulakendu Bhattacharya"
Article Synopsis
- A study investigated the effectiveness of individualized homeopathic medicinal products (IHMPs) compared to placebos for improving health-related quality of life in individuals suffering from post-COVID-19 conditions, with up to 80% of infected individuals experiencing ongoing symptoms.* -
- Conducted at a medical college in India, the trial involved 60 participants divided into two groups: one receiving IHMPs plus care and the other receiving placebos plus care. The study tracked health outcomes over three months using established assessment tools.* -
- Results showed that IHMPs significantly outperformed placebos in reducing post-COVID-19 symptoms, with notable improvements in both primary and secondary outcome measures, suggesting promise for homeopathic treatments in future
Introduction: This study aimed at examining the feasibility issues of comparing individualized homeopathic medicines (IHMs) with identical-looking placebos for treating knee osteoarthritis (OA).
Methods: Forty eligible patients participated in this double-blind, randomized (1:1), placebo-controlled feasibility trial in the outpatient clinics of a homeopathic hospital in West Bengal, India. Either IHMs or identical-looking placebos were administered, along with mutually agreed-upon concomitant care guidelines.
Introduction: Hyperuricemia (HU) is a major health issue in India and across the globe. It increases the disease burden and hampers quality of life. This study was aimed at exploring the effects of individualized homeopathic medicines (IHMs) against placebo in the treatment of HU.
View Article and Find Full Text PDFIntroduction: There is some evidence that homeopathic treatment has been used successfully in previous epidemics, and currently some countries are testing homeoprophylaxis for the coronavirus disease 2019 (COVID-19) pandemic. There is a strong tradition of homeopathic treatment in India: therefore, we decided to compare three different homeopathic medicines against placebo in prevention of COVID-19 infections.
Methods: In this double-blind, cluster-randomized, placebo-controlled, four parallel arms, community-based, clinical trial, a 20,000-person sample of the population residing in Ward Number 57 of the Tangra area, Kolkata, was randomized in a 1:1:1:1 ratio of clusters to receive one of three homeopathic medicines ( 30cH, 30cH, 30cH) or identical-looking placebo, for 3 (children) or 6 (adults) days.